中、晚期肝癌介入治疗预后的影响因素分析

doi:10.3969/j.issn.1672-5069.2015.02.028

Abstract

Wu Zhaoyu. Risk factors of prognosis in patients with advanced liver cancer after transcather arterial chemoembolization[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2015, 18(4): 427-429.

[1] 陈建国，张思维，陈万青，等. 中国2004-2005年全国死因回顾抽样调查肝癌死亡率分析.中华预防医学杂志，2010，44（5）：383-389.
[2] Wu GL，Zhang L，Li TY，et al. Short-term effect of combined therapy with Jinlong capsule and transcatheter arterial chemoembolization on patients with primary hepatic carcinoma and its influence on serum osteopontin expression. Chin J Integr Med，2010，16（2）：109-113.
[3] 张玉鹏，李昭宇，赵伟，等.影响中晚期原发性肝癌患者的生存因素分析.宁夏医科大学学报，2013，35（4）：402-406.
[4] 张崇高，王国林. 肝动脉化疗栓塞联合微波消融治疗原发性肝癌临床疗效分析. 实用肝脏病杂志，2011，14（5）：378-379.
[5] Min YW，Kim J，Kim S，et al. Risk factors and a predictive model for acute hepatic failure after transcatheter arterial chemoembolization in patients with hepatocellular carcinoma. Liver Int，2013，33（2）：197-202.
[6] Yin X，Zhang BH，Qiu SJ，et al. Combined hepatocellular carcinoma and cholangiocarcinoma：clinical features，treatment modalities，and prognosis. Ann Surg Oncol，2012，19（9）：2869-2876.
[7] Maeda S，Wada H，Tanemura M，et al. A case of hepatocellular carcinoma treated by transcatheter arterial chemoembolization and hepatectomy after subtotal stomach preserving pancreaticoduodenectomy for duodenal cancer. Gan To Kagaku Ryoho，2012，39（12）：1988-1990.
[8] 谭新劲，任丽，刘晋湘，等. TACE联合三维适形放疗治疗中晚期原发性肝癌疗效观察. 实用肝脏病杂志，2011，14（6）：433-435.
[9] 倪嘉延，许林锋，陈耀庭，等. 联合介入治疗中晚期原发性肝癌远期疗效及影响因素分析.中山大学学报（医学科学版），2013，34（5）：734-738.
[10] 王守峰，张金岭，殷忠美，等. 不同Child分级的高HBVDNA滴度原发性肝癌介入治疗后肝功能损害的对比研究.中国肿瘤外科杂志，2013，5（3）：160-162.
[11] Nishikawa H，Osaki Y，Kita R，et al. Comparison of transcatheter arterial chemoembolization and transcatheter arterial chemotherapy infusion for patients with intermediate-stage hepatocellular carcinoma. Oncol Rep，2014，31（1）：65-72.
[12] Matsuda M，Omata F，Fuwa S，et al. Prognosis of patients with hepatocellular carcinoma treated solely with transcatheter arterial chemoembolization： risk factors for one-year recurrence and two-year mortality（preliminary data）. Intern Med，2013，52（8）：847-853.
[13] Yoon HM， Kim JH，Kim EJ，et al. Modified cisplatin-based transcatheter arterial chemoembolization for large hepatocellular carcinoma：multivariate analysis of predictive factors for tumor response and survival in a 163-patient cohort. J Vasc Interv Radiol，2013，24（11）：1639-1646.

[1]	Zhu Yucheng, Yan Jiawei, Sun Jingkun, et al. Serum diamine oxidase level in patients with hepatitis B-induced acute-on-chronic liver failure [J]. Journal of Practical Hepatology, 2019, 22(5): 672-675.
[2]	Wang Gang, Zhao Hongbo, Zhu Yaling, et al. Cancerous XPO5 gene level in patients with hepatocellular carcinoma and its clinical significance [J]. Journal of Practical Hepatology, 2019, 22(5): 724-727.
[3]	Liu Xing, Zhao Shuli, Zhang Dianlong. Effect of sevoflurane inhalation on hepatic ischemia-reperfusion injury in patients with primary liver cancer undergoing partial hepatectomy [J]. Journal of Practical Hepatology, 2019, 22(5): 728-731.
[4]	Pei Ying, Huang Feng, Yin Hongzhen, et al. Preliminary study on intestinal microecology in mice with xenograft hepatoma intervened by sodiumnorcantharidate [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 486-489.
[5]	Zhuang Taiping, Yin Yangyan, Xie Manfang, et al. Comparison of clinical features of infants with human cytomegalovirus infection and of infantile hepatitis syndrome [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 514-517.
[6]	Peng Silu, Liu Bing, Sun Hong, et al. Prognosis of patients with hepatitis B-induced acute-on-chronic liver failure [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 545-548.
[7]	Dai Qingyun, Wang Rundong, Jia Weidong. Prediction of early tumor recurrence by predictive nutritional index in patients with hepatocellular carcinoma undergoing hepatectomy [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 561-564.
[8]	Cui Faqiang, Li Tao, Wang Zheng, et al. A pilot study on cetuximab and KRAS gene mutation in treatment of patients with primary liver cancer [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 565-568.
[9]	Yang Fucun, Shang Huaixue, Gai Yonghao. Enhanced magnetic resonance imaging by gadolinium disodium sebacate in diagnosis of patients with focal liver lesions [J]. Journal of Practical Hepatology, 2019, 22(4): 577-580.
[10]	Peng Xinjian, Xiao Yuhui, Xu Siding. Diagnostic value of diffusion-weighted magnetic resonance imaging in patients with radiation-induced liver injury with underlying hepatocelullar carcinoma [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(3): 373-376.
[11]	Zhao Xiaoguang, Shi Yujie. Protective effect of reduced glutathione on liver function in patients with advanced primary liver cancer underwent transarterial chemoembolization [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(3): 425-428.
[12]	Zhang Tingting, Wang Xuan. Clinical implications of oral glucose tolerance test in cirrhotic patients with hepatogenous diabetes [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(3): 449-452.
[13]	Gao Pengbin, Zhao Xiaoyan, Qin Hao, Wu Fengying, Zhang Haizhen, Wang Lin, Jia Huina, Li Shujuan. Risk factors for poor prognosis of patients with hepatitis E-induced liver failure [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 220-223.
[14]	Wang Huming, Fan Dongsheng, Xu Jie, Liu Xianfegn, Zhou Ning, Li Min, Bao Nana. Cancerous miRNA-30c levels affecting the survival of patients with hepatocellular carcinoma after hepatectomy [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 248-251.
[15]	Li Ketian, Shen Mingge, Wang Fengrong, Hu Chunrong, Cao Yujie, Lu Peng. Impact of blood glucose levels on imaging quality of PET/CT examination in patients with primary liver cancer [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 256-259.

Risk factors of prognosis in patients with advanced liver cancer after transcather arterial chemoembolization

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments